RhumbLine Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,198,565
Closed -$119M 2986
2019
Q3
$119M Buy
1,198,565
+23,035
+2% +$2.19M 0.22% 86
2019
Q2
$109M Buy
1,175,530
+434
+0% +$41.2K 0.2% 93
2019
Q1
$111M Buy
1,175,096
+54,050
+5% +$4.73M 0.21% 89
2018
Q4
$71.8M Sell
1,121,046
-6,606
-0.6% -$488K 0.16% 125
2018
Q3
$101M Sell
1,127,652
-34,440
-3% -$3.04M 0.19% 100
2018
Q2
$92.3M Sell
1,162,092
-20,624
-2% -$1.71M 0.19% 106
2018
Q1
$106M Sell
1,182,716
-51,919
-4% -$4.98M 0.22% 88
2017
Q4
$129M Sell
1,234,635
-90,069
-7% -$10.2M 0.26% 72
2017
Q3
$193M Buy
1,324,704
+12,344
+0.9% +$1.68M 0.42% 41
2017
Q2
$170M Buy
1,312,360
+32,357
+3% +$3.96M 0.39% 42
2017
Q1
$159M Buy
1,280,003
+10,679
+0.8% +$1.28M 0.37% 43
2016
Q4
$147M Buy
1,269,324
+36,632
+3% +$4.08M 0.37% 47
2016
Q3
$129M Buy
1,232,692
+42,159
+4% +$4.56M 0.36% 48
2016
Q2
$117M Buy
1,190,533
+41,312
+4% +$4.27M 0.35% 50
2016
Q1
$115M Buy
1,149,221
+36,689
+3% +$3.78M 0.36% 52
2015
Q4
$133M Sell
1,112,532
-6,767
-0.6% -$783K 0.43% 44
2015
Q3
$121M Buy
1,119,299
+14,304
+1% +$1.78M 0.41% 47
2015
Q2
$128M Sell
1,104,995
-199,638
-15% -$22.8M 0.41% 46
2015
Q1
$150M Sell
1,304,633
-12,315
-0.9% -$1.47M 0.43% 47
2014
Q4
$147M Sell
1,316,948
-24,334
-2% -$2.57M 0.43% 43
2014
Q3
$127M Sell
1,341,282
-26,114
-2% -$2.36M 0.38% 49
2014
Q2
$117M Sell
1,367,396
-84,698
-6% -$6.44M 0.34% 56
2014
Q1
$101M Sell
1,452,094
-24,800
-2% -$1.96M 0.3% 69
2013
Q4
$125M Sell
1,476,894
-71,238
-5% -$5.64M 0.37% 53
2013
Q3
$119M Sell
1,548,132
-52,570
-3% -$3.68M 0.37% 53
2013
Q2
$93.6M Buy
+1,600,702
New +$96.3M 0.3% 65

Other funds holding CELG

RhumbLine Advisers's CELG Position: Q4 2019 in Review

RhumbLine Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,198,565 shares — an estimated $119M sold.

RhumbLine Advisers first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $193M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RhumbLine Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 1,198,565 Celgene Corp shares in Q4 2019, an estimated $119M.
  • RhumbLine Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • RhumbLine Advisers's Celgene Corp position peaked at $193M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.